AUGUSTINE THERAPEUTICS
Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors for the treatment of axonopathies such as Charcot Marie Tooth disease. These new compounds have the potential to protect from nerve degeneration and promote peripheral myelin and axon repair.
AUGUSTINE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-03-01
Address:
Leuven, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.augustinetx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
21.2 M EUR
Technology used in webpage:
Google Maps Google Maps API Google Maps For Work Belgian Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Investors List
PMV
PMV investment in Series A - Augustine Therapeutics
V-Bio Ventures
V-Bio Ventures investment in Series A - Augustine Therapeutics
AdBio partners
AdBio partners investment in Series A - Augustine Therapeutics
Eli Lilly
Eli Lilly investment in Series A - Augustine Therapeutics
CMT Research Foundation
CMT Research Foundation investment in Series A - Augustine Therapeutics
Gemma Frisius Fund
Gemma Frisius Fund investment in Series A - Augustine Therapeutics
VIB
VIB investment in Series A - Augustine Therapeutics
Asabys Partners
Asabys Partners investment in Series A - Augustine Therapeutics
AdBio partners
AdBio partners investment in Seed Round - Augustine Therapeutics
PMV
PMV investment in Seed Round - Augustine Therapeutics
Official Site Inspections
http://www.augustinetx.com Semrush global rank: 8.27 M Semrush visits lastest month: 588
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Augustine Therapeutics"
Augustine - Novel HDAC6 Inhibitors for Chronic Disease
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover โฆSee details»
Augustine Therapeutics - LinkedIn
Augustine Therapeutics | 4,238 followers on LinkedIn. Innovative Therapies for Neuromuscular, Neurodegenerative and Cardio-metabolic Diseases | Augustine Therapeutics is a biotechnology company ...See details»
Augustine Therapeutics - Crunchbase Company Profile & Funding
Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors for the treatment of axonopathies such as Charcot Marie Tooth โฆSee details»
Augustine Therapeutics 2025 Company Profile: โฆ
Information on valuation, funding, cap tables, investors, and executives for Augustine Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Augustine Therapeutics - Craft
Augustine Therapeutics is a company building drug discovery programs to find treatment for neurological diseases. It focuses on the discovery and development of medicines to help โฆSee details»
VIB
Mar 24, 2025 With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics โฆSee details»
Augustine Therapeutics NV - Drug pipelines, Patents, Clinical trials ...
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into โฆSee details»
Augustine Therapeutics - Asabys Partners
Augustine Therapeutics is a Belgian biotech company founded in 2019 and a spin-off of VIB-KU Leuven. The company is developing a wide portfolio of best-in-class, novel, potent and subtype-selective small-molecule inhibitors of the โฆSee details»
Augustine Therapeutics - VentureRadar
"Augustine Therapeutics is a biotech company focused on the development of novel treatments for neurodegenerative and cardiometabolic diseases. They are working on building a portfolio โฆSee details»
2025.02.13 Augustine CEO PR ICR Healthcare final draft for โฆ
Feb 13, 2025 Its scientific foundation originates from the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven Center for Brain and Disease Research, tackling the โฆSee details»
Augustine Therapeutics - PMV
PMV is one of the investors in Augustine Therapeutics, a new venture of the Flemish Institute of Biotechnology (VIB) and KU Leuven. The spin-off develops innovative therapies for patients suffering from Charcot-Marie-Tooth disease โฆSee details»
Augustine Therapeutics NV (Augustine Therapeutics NV) - ่ฏ็ฉ็ฎก โฆ
Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. For more information visit www.augustinetx.com. โฆSee details»
Augustine Therapeutics appoints Gerhard Koenig as Chief
Feb 13, 2025 Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD,...See details»
Augustine Therapeutics - EU-Startups
Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors and GABABR1a activators for the treatment of neurological โฆSee details»
Augustine Therapeutics: Revenue, Worth, Valuation & Competitors โฆ
About Augustine Therapeutics Augustine Therapeutics is a Biotech related company founded in 2019 and based in Leuven with an estimated revenue of -, and. It has 10 competitors including โฆSee details»
A story of continued growth: the Augustine Tx journey - LinkedIn
Dec 20, 2021 Augustine Therapeutics was created in 2019, thanks to the pioneering research of scientists at the VIB-KU Leuven Center for Brain & Disease Research. The startupโs aim is to โฆSee details»
Augustine Therapeutics awarded EUR 1.2 million VLAIO research
Mar 23, 2021 More information at www.augustinetx.com. About VLAIO The Agency for Innovation and Entrepreneurship (VLAIO) is an organization of the Flemish government for all โฆSee details»
Augustine Therapeutics Raises Eur 17 Million In A Series A
READ THIS NEWS IN SPANISH Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6 inhibitor, into a first-in-human clinical Phase 1/2 โฆSee details»
Privacy Policy | Augustine Therapeutics
Augustine Therapeutics NV (โAugustineโ, โweโ) respects your privacy and data protection rights and recognizes the importance of protecting the personal data we collect and process when โฆSee details»
VIB
Ghent, 26 June 2024 โ VIB, Flandersโ leading life sciences research institute announces today that one of its spin-off companies, Augustine Therapeutics, has raised EUR 17 million (USD โฆSee details»